MORGAN MYERS: Open Payments
NPI 1770268401 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 107 payments from 17 companies in 2025. Trend: 2023 $337 · 2024 $1,934 · 2025 $1,868
Food & beverage: $1,868
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $509 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $323 |
| Aimmune Therapeutics, Inc. | 10 | $186 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Lilly USA, LLC | 6 | $103 |
| Phathom Pharmaceuticals, Inc. | 10 | $100 |
| Gilead Sciences, Inc. | 5 | $90 |
| GENZYME CORPORATION | 3 | $83 |
| Janssen Biotech, Inc. | 4 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
Products named: RINVOQ, DUPIXENT, ENTYVIO, CREON, EOHILIA, ZENPEP, OMVOH, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
